Francesco Marampon

Pubblicazioni

Titolo	Pubblicato in	Anno
The evolving role of reirradiation in the management of recurrent brain tumors	JOURNAL OF NEURO-ONCOLOGY	2023
Surgery‐ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy	HEAD & NECK	2023
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov	RADIATION ONCOLOGY	2023
The evolving role of reirradiation in the management of recurrent brain tumors	JOURNAL OF NEURO-ONCOLOGY	2023
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status	JOURNAL OF NEURO-ONCOLOGY	2023
ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma	CANCERS	2022
The botanical drug PBI-05204, a supercritical CO2 extract of nerium oleander, is synergistic with radiotherapy in models of human glioblastoma	FRONTIERS IN PHARMACOLOGY	2022
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression	FRONTIERS IN ONCOLOGY	2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma	ONCOLOGY REPORTS	2022
Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma	CANCER RESEARCH	2022
Radioresistance in rhabdomyosarcomas: much more than a question of dose	FRONTIERS IN ONCOLOGY	2022
Translational implications for radiosensitizing strategies in rhabdomyosarcoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo	FRONTIERS IN PHARMACOLOGY	2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications	CANCERS	2022
Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review	BJR CASE REPORTS	2022
The prostacyclin analogue Iloprost modulates CXCL10 in systemic sclerosis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors	CELLS	2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications	CANCERS	2022
New Insights on the Nuclear Functions and Targeting of {FAK} in Cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
A pilot surveillance investigation on the influence of a probiotic combination on side-effects caused by common anti-cancer therapies	Reports of Practical Oncology Radiotherapy	2022

Pubblicazioni

Progetti di Ricerca